ATP6AP1 and breast carcinoma: To assess whether ATP6AP1 affects TAM resistance, we first analyzed the prognostic significance of the altered expression of ATP6AP1 in luminal breast cancer patients who received TAM chemotherapy using the Kaplan‒Meier plotter database.